<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d613">
    <sentence id="DDI-DrugBank.d613.s0" text="A study published in 2002 found that vigabatrin causes a statistically significant increase in plasma clearance of carbamazepine. ">
        <entity id="DDI-DrugBank.d613.s0.e0" charOffset="37-46"
            type="drug" text="vigabatrin"/>
        <entity id="DDI-DrugBank.d613.s0.e1" charOffset="115-127"
            type="drug" text="carbamazepine"/>
        <pair id="DDI-DrugBank.d613.s0.p0" e1="DDI-DrugBank.d613.s0.e0"
            e2="DDI-DrugBank.d613.s0.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d613.s1" text="In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy. ">
        <entity id="DDI-DrugBank.d613.s1.e0" charOffset="87-96"
            type="drug" text="vigabatrin"/>
        <entity id="DDI-DrugBank.d613.s1.e1" charOffset="103-111"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d613.s1.e2" charOffset="131-139"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d613.s1.p0" e1="DDI-DrugBank.d613.s1.e0"
            e2="DDI-DrugBank.d613.s1.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d613.s1.p1" e1="DDI-DrugBank.d613.s1.e0"
            e2="DDI-DrugBank.d613.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d613.s1.p2" e1="DDI-DrugBank.d613.s1.e1"
            e2="DDI-DrugBank.d613.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d613.s2" text="The concentration of phenytoin falls to 23% within five weeks, according to an experiment published in 1989 by the same two scientists that tried and failed to elucidate the mechanism behind this interaction.">
        <entity id="DDI-DrugBank.d613.s2.e0" charOffset="21-29"
            type="drug" text="phenytoin"/>
    </sentence>
</document>
